Cited by 4,173RNA Interference and Gene DeliveryVirus-based gene therapy researchIntramuscular injections and effects

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Direct Gene Transfer into Mouse Muscle in Vivo

Wolff, Jon A., Malone, Robert W., Williams, Phillip, Chong, Wang, Acsadi, Gyula, Jani, Agnes, Felgner, Philip L.·1990·Science

DOI 10.1126/science.1690918

Open this paper in CoChat — free account

Abstract

RNA and DNA expression vectors containing genes for chloramphenicol acetyltransferase, luciferase, and β-galactosidase were separately injected into mouse skeletal muscle in vivo. Protein expression was readily detected in all cases, and no special delivery system was required for these effects. The extent of expression from both the RNA and DNA constructs was comparable to that obtained from fibroblasts transfected in vitro under optimal conditions. In situ cytochemical staining for β-galactosidase activity was localized to muscle cells following injection of the β-galactosidase DNA vector. After injection of the DNA luciferase expression vector, luciferase activity was present in the muscle for at least 2 months.

Integrity signals

Registry

Crossref · 10.1126/science.1690918

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,674
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,102
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., RINGOLD, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,954
Self-citation
Firefly Luciferase Gene: Structure and Expression in Mammalian Cells
de Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R., & Subramani, S. E. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.725 · Cited by 3,088
Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs
Krieg, P. A., & Melton, D. A. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.18.7057 · Cited by 1,533
The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.
Gorman, C. M., Merlino, G. T., Willingham, M. C., Pastan, I. H., & Howard, B. H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.22.6777 · Cited by 1,257
Cationic liposome-mediated transfection
Felgner, P. L., & RINGOLD, G. M. (1989) · Nature · doi:10.1038/337387a0 · Cited by 989
Self-citation
Cationic liposome-mediated RNA transfection.
Malone, R. W., Felgner, P. L., & Verma, I. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6077 · Cited by 911
Self-citation
Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer.
Price, J., Turner, D., & Cepko, C. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.156 · Cited by 870
Receptor-mediated gene delivery and expression in vivo.
Wu, G. Y., & Wu, C. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68081-0 · Cited by 636

Flagged first, then by citations

Show all 27 references

Research works printed but not linked: 3

FELGNER, P.L., FOCUS 11: 21 (1989).
FRANZINIARMSTRO.C, MYOLOGY: 125 (1986).
MALONE, R.W., FOCUS 11: 61 (1989).

Sorted by citations

Items 701–800 of 1,009

Vaccination with Allergen-IL-18 Fusion DNA Protects Against, and Reverses Established, Airway Hyperreactivity in a Murine Asthma Model
Maecker, H. T., Hansen, G., Walter, D. M., DeKruyff, R. H., Levy, S., & Umetsu, D. T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.959 · Cited by 90
A Novel Gene Delivery System Using Urothelial Tissue Engineered Neo-Organs
Yoo, J. J., & Atala, A. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)64390-8 · Cited by 90
Immune Response to Neonatal Genetic Immunization
Wang, Y., Xiang, Z., Pasquini, S., & Ertl, H. C. J. (1997) · Virology · doi:10.1006/viro.1996.8384 · Cited by 90
Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis.
Koh, G. Y., Kim, S. J., Klug, M. G., Park, K., Soonpaa, M. H., & Field, L. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117627 · Cited by 90
CD 8 T‐cell priming upon mRNA vaccination is restricted to bone‐marrow‐derived antigen‐presenting cells and may involve antigen transfer from myocytes
Lazzaro, S., Giovani, C., Mangiavacchi, S., Magini, D., Maione, D., Baudner, B. C., Geall, A. J., Gregorio, E. D., D’Oro, U., & Buonsanti, C. (2015) · Immunology · doi:10.1111/imm.12505 · Cited by 89
RNA Therapy: Current Status and Future Potential
Kim, Y. (2020) · Chonnam Medical Journal · doi:10.4068/cmj.2020.56.2.87 · Cited by 91
Gene Delivery to Muscle
Springer, M. L., Rando, T. A., & Blau, H. M. (2001) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1304s31 · Cited by 89
Photon correlation spectroscopy investigations of proteins
Гунько, В. М., Klyueva, A. V., Levchuk, Y. N., & Leboda, R. (2003) · Advances in Colloid and Interface Science · doi:10.1016/s0001-8686(03)00091-5 · Cited by 89
Modified Escherichia coli B (BL21), a superior producer of plasmid DNA compared with Escherichia coli K (DH5α)
Phue, J., Lee, S. J., Trinh, L. B., & Shiloach, J. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21973 · Cited by 89
Specific Interaction of the Actin-binding Domain of Dystrophin with Intermediate Filaments Containing Keratin 19
Stone, M. R., O’Neill, A., Catino, D. H., & Bloch, R. J. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-02-0112 · Cited by 89
Nucleic acid vaccines
Vogel, F. R., & Sarver, N. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.3.406 · Cited by 89
DNA vaccines: safety and efficacy issues
Klinman, D. M., Takeno, M., Ichino, M., Gu, M., Yamshchikov, G. V., Mor, G., & Conover, J. (1997) · Springer Seminars in Immunopathology · doi:10.1007/bf00870272 · Cited by 88
METHODS OF GENE DELIVERY
Wivel, N. A., & Wilson, J. M. (1998) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70004-6 · Cited by 89
Expression and Immune Response to Hepatitis C Virus Core Dna-Based Vaccine Constructs
Tokushige, K., Wakita, T., Pachuk, C. J., Moradpour, D., Weiner, D. B., Zurawski, V. R., & Wands, J. R. (1996) · Hepatology · doi:10.1002/hep.510240104 · Cited by 89
DNA vaccines: A novel approach to immunization
Fynan, E. F., Webster, R. G., FULLER, D. H., Haynes, J. R., Santoro, J. C., & Robinson, H. L. (1995) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(94)00090-b · Cited by 89
Histochemical Staining Following LacZ Gene Transfer Underestimates Transfection Efficiency
Couffinhal, T., Kearney, M., Sullivan, A. B., Silver, M., Tsurumi, Y., & Isner, J. M. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.8-929 · Cited by 89
Tetracycline-regulated cardiac gene expression in vivo.
Fishman, G. I., Kaplan, M. L., & Buttrick, P. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117174 · Cited by 89
Synthetic modified messenger RNA for therapeutic applications
Gao, M., Zhang, Q., Feng, X.-H., & Liu, J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.06.020 · Cited by 89
A cGAS-Independent STING/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines
Suschak, J. J., Wang, S., Fitzgerald, K. A., & Lu, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501836 · Cited by 87
Design concepts of polyplex micelles for in vivo therapeutic delivery of plasmid DNA and messenger RNA
Uchida, S., & Kataoka, K. (2019) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36614 · Cited by 90
Peptide-mediated delivery of therapeutic mRNA in ovarian cancer
van den Brand, D., Gorris, M. A. J., van Asbeck, A. H., Palmen, E., Ebisch, I. M. W., Dolstra, H., Hällbrink, M., Massuger, L. F. A. G., & Brock, R. E. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.05.014 · Cited by 88
Nucleic Acid Drugs—Current Status, Issues, and Expectations for Exosomes
Yamada, Y. (2021) · Cancers · doi:10.3390/cancers13195002 · Cited by 92
A muscle-targeting peptide displayed on AAV2 improves muscle tropism on systemic delivery
Yu, C.-Y., Yuan, Z., Cao, Z., Wang, B., Qiao, C., Li, J., & Xiao, X. (2009) · Gene Therapy · doi:10.1038/gt.2009.59 · Cited by 90
Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles
Xiang, S. D., Selomulya, C., Ho, J., Apostolopoulos, V., & Plebanski, M. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.88 · Cited by 88
Effect of the Nature of the Spacer on Gene Transfer Efficacies of Novel Thiocholesterol Derived Gemini Lipids in Different Cell Lines: A Structure–Activity Investigation
Bajaj, A., Kondaiah, P., & Bhattacharya, S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7010436 · Cited by 88
Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA
Karikó, K., Kuo, A., & Barnathan, E. S. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300930 · Cited by 89
The role of microRNAs in chronic respiratory disease: recent insights
Stolzenburg, L. R., & Harris, A. (2017) · Biological Chemistry · doi:10.1515/hsz-2017-0249 · Cited by 91
“Though the efficacy of naked nucleic acids in rodent models were demonstrated clearly (Wolff et al., 1990; Henry et al., 2011), RNA activity and safety in humans is restricted by stability, cellular uptake, target specificity and immune activation.”
α-Amino acid N-carboxyanhydride (NCA)-derived synthetic polypeptides for nucleic acids delivery
Liu, Y., & Yin, L. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.007 · Cited by 87
Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants
Bouazzaoui, A., Abdellatif, A. A. H., Al-Allaf, F. A., Bogari, N. M., Al-Dehlawi, S., & Qari, S. H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020140 · Cited by 92
“demonstrated that mice injected with plasmids harboring a cloned protein subsequently showed an expression of the transgenic protein cloned in the plasmid DNA [12].”
BackgroundResult
COVID-19 mRNA vaccines
Huang, Q., Zeng, J., & Yan, J. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.02.006 · Cited by 91
“In 1990, the successful in vivo use of in vitro transcribed (IVT) mRNA was firstly reported with the detection of protein production from reporter gene mRNA directly administrated into mouse muscle (Wolff et al., 1990).”
Background
Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
Yu, A., & Tu, M. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107967 · Cited by 94
“the expression of encoded proteins or vaccination (Jirikowski et al., 1992; Martinon et al., 1993; Wolff et al., 1990), many therapeutic mRNAs and vaccines have entered into clinical investigations to combat against various diseases (clinicaltrials.”
Background
A Biopharmaceutical Perspective on Higher-Order Structure and Thermal Stability of mRNA Vaccines
Kloczewiak, M. A., Banks, J. M., Jin, L., & Brader, M. L. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00092 · Cited by 90
mRNA nanodelivery systems: targeting strategies and administration routes
Yuan, M., Han, Z., Liang, Y., Sun, Y., He, B., Chen, W., & Fan, L. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00425-3 · Cited by 98
“found for the first time that injecting in vitro transcription (IVT) messenger ribonucleic acid (mRNA) could produce proteins successfully in mice [1].”
Background
Recent progress in mRNA cancer vaccines
Yao, R., Xie, C., & Xia, X. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2307187 · Cited by 91
“11 In the early 1990s, efforts to develop mRNA vaccines for tumor prevention commenced.”
Background
vaccination with the EtMIC2 gene induces protective immunity against coccidiosis
Ding, X., Lillehoj, H. S., Dalloul, R. A., Min, W., Sato, T., Yasuda, A., & Lillehoj, E. P. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.144 · Cited by 87
Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response
Kurar, E. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00140-0 · Cited by 87
Genetic immunisation against hepatitis B using whole bacteriophage λ particles
March, J. B., Clark, J. R., & Jepson, C. D. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.10.047 · Cited by 87
Animal models of muscular dystrophy – what can they teach us?
Partridge, T. A. (1991) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1991.tb00735.x · Cited by 85
Tuberculosis DNA Vaccine Encoding Ag85A Is Immunogenic and Protective When Administered by Intramuscular Needle Injection but Not by Epidermal Gene Gun Bombardment
Tanghe, A., Denis, O., Lambrecht, B., Motte, V., van den Berg, T., & Huygen, K. (2000) · Infection and Immunity · doi:10.1128/iai.68.7.3854-3860.2000 · Cited by 87
mRNA Cancer Vaccines
Fiedler, K., Lazzaro, S., Lutz, J., Rauch, S., & Heidenreich, R. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42934-2_5 · Cited by 88
PEO-PPO-PEO Tri-Block Copolymers for Gene Delivery Applications in Human Regenerative Medicine—An Overview
Rey‐Rico, A., & Cucchiarini, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030775 · Cited by 91
Advancements in mRNA Encoded Antibodies for Passive Immunotherapy
Deal, C. E., Carfı́, A., & Plante, O. J. (2021) · Vaccines · doi:10.3390/vaccines9020108 · Cited by 90
“Protein expression from exogenous mRNA was demonstrated in vivo two decades ago when direct injection of mRNA into mouse muscle was shown to result in local protein expression [61]; however, there are still several hurdles that need to be solved.”
Background
Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination
de Assis, R. R., Jain, A., Nakajima, R., Jasinskas, A., Khan, S., Palma, A. M., Parker, D. M., Chau, A. H., Specimen Collection Group, Hosseinian, S., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00396-3 · Cited by 86
“[11, 12] After intramuscular (IM) injection of a plasmid encoding HIV gp120, induction of anti-gp120 Abs was reported[13].”
BackgroundSelf-citation
A new developing class of gene delivery: messenger RNA-based therapeutics
Zhao, M., Ahern, J. O., Lyu, J., Pierucci, L., Zhou, D., & Wang, W. (2017) · Biomaterials Science · doi:10.1039/c7bm00712d · Cited by 95
Dose Dependence of CTL Precursor Frequency Induced by a DNA Vaccine and Correlation with Protective Immunity Against Influenza Virus Challenge
Fu, T., Guan, L., Friedman, A., Schofield, T. L., Ulmer, J. B., Liu, M. A., & Donnelly, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4163 · Cited by 86
Expression of recombinant dystrophin and its localization to the cell membrane
Lee, C. C., Pearlman, J. A., Chamberlain, J. S., & Caskey, C. T. (1991) · Nature · doi:10.1038/349334a0 · Cited by 86
Bacterial Lipopolysaccharide Copurifies with Plasmid DNA: Implications for Animal Models and Human Gene Therapy
Wicks, I. P., Howell, M. L., Hancock, T., Kohsaka, H., Olee, T., & Carson, D. A. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.3-317 · Cited by 86
Cellular and molecular adaptations to injurious mechanical stress
McNeil, P. L. (1993) · Trends in Cell Biology · doi:10.1016/0962-8924(93)90012-p · Cited by 86
Immune Response to a Hepatitis B DNA Vaccine in Aotus Monkeys: A Comparison of Vaccine Formulation, Route, and Method of Administration
Gramzinski, R. A., Millan, C. L. B., Obaldía, N., Hoffman, S. L., & Davis, H. L. (1998) · Molecular Medicine · doi:10.1007/bf03401734 · Cited by 85
Mutagenic effects of tumorigenic neutron radiation
García‐España, A., Kahn, J. M., Sáez, G. T., & Pellicer, À. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960301)65:5 · Cited by 3
Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
Mansanguan, S., Charunwatthana, P., Piyaphanee, W., Dechkhajorn, W., Poolcharoen, A., & Mansanguan, C. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7080196 · Cited by 83
“Endosomal toll-like receptor (TLR) TLR3, TLR7, and TLR8 in immune cells and RIG-I and MDA5 in nonimmune cells act as a natural defense against foreign RNA but can crossreact with in vitro transcribed (IVT) RNA [26].”
Management of Hereditary Retinal Degenerations
Sharma, R., Sc, L. M., & Ehinger, B. (1999) · Survey of Ophthalmology · doi:10.1016/s0039-6257(99)00006-5 · Cited by 84
Optimization of Skin Electroporation in Mice to Increase Tolerability of DNA Vaccine Delivery to Patients
Roos, A., Eriksson, F., Walters, D. C., Pisa, P., & KING, A. D. (2009) · Molecular Therapy · doi:10.1038/mt.2009.120 · Cited by 85
Intradermal Delivery of Interleukin-12 Plasmid DNA by in vivo Electroporation
Heller, R. F., Schultz, J. G., Lucas, M. L., Jaroszeski, M. J., Heller, L. C., Gilbert, R. A., Moelling, K., & Nicolau, C. S. (2001) · DNA and Cell Biology · doi:10.1089/10445490150504666 · Cited by 85
Tissue Distribution and Persistence in Mice of Plasmid DNA Encapsulated in a PLGA-Based Microsphere Delivery Vehicle
Lunsford, L. B., McKeever, U., Eckstein, V., & Hedley, M. L. (2000) · Journal of drug targeting · doi:10.3109/10611860009009208 · Cited by 85
Enhancement of Cellular Immune Response in HIV-1 Seropositive Individuals: A DNA-Based Trial
Boyer, J., Chattergoon, M. A., Ugen, K. E., Shah, A. R., Bennett, M. K., Cohen, A. D., Nyland, S. B., Lacy, K. E., Bagarazzi, M. L., Higgins, T. J., et al. (1999) · Clinical Immunology · doi:10.1006/clim.1998.4616 · Cited by 85
Characterization of the ribonuclease activity on the skin surface
Probst, J., Brechtel, S., Scheel, B., Hoerr, I., Jung, G., Rammensee, H.-G., & Pascolo, S. (2006) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-4-4 · Cited by 84
A review: Progress in the development of fish Vibrio spp. vaccines
Ji, Q., Wang, S., Ma, J., & Liu, Q. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.07.002 · Cited by 84
A cationic cholesterol based nanocarrier for the delivery of p53-EGFP-C3 plasmid to cancer cells
Misra, S. K., Naz, S., Kondaiah, P., & Bhattacharya, S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.062 · Cited by 84
Approaches to Enhance the Efficacy of DNA Vaccines
Manoj, S., Babiuk, L. A., & den Hurk, S. V. D. L. (2004) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360490269251 · Cited by 84
Systemic Administration of IL-18 Promotes Diabetes Development in Young Nonobese Diabetic Mice
Oikawa, Y., Shimada, A., Kasuga, A., Morimoto, J., Osaki, T., Tahara, H., Miyazaki, T., Tashiro, F., Yamato, E., Miyazaki, J., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5865 · Cited by 84
Structural and Functional Differences in the Promoter and 5′ Flanking Region of Ldh-B Within and Between Populations of the Teleost Fundulus heteroclitus
Schulte, P. M., Marta Gómez-chiarri, G., & Powers, D. A. (1997) · Genetics · doi:10.1093/genetics/145.3.759 · Cited by 84
Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene
Sin, J. (1997) · Vaccine · doi:10.1016/s0264-410x(97)88856-1 · Cited by 84
Slow Accumulation of Plasmid in Muscle Cells: Supporting Evidence for a Mechanism of DNA Uptake by Receptor-Mediated Endocytosis
Šatkauskas, S., Bureau, M. F., Mahfoudi, A., & Mir, L. M. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0465 · Cited by 84
Concepts and strategies for human gene therapy
Roemer, K., & Friedmann, T. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17176.x · Cited by 84
Eliciting antitumor immunity via therapeutic cancer vaccines
Peng, K., Zhao, X., Fu, Y., & Liang, Y. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01316-4 · Cited by 104
“By the early 1990s, researchers demonstrated that naked or liposome-encapsulated mRNAs could induce protein expression and activate antigen-speci ﬁ c cytotoxic T cells in vivo [204, 205].”
Phase 1 Trial of Intranodal Injection of a Melan-A/MART-1 DNA Plasmid Vaccine in Patients With Stage IV Melanoma
Weber, J. S., Boswell, W. D., Smith, J. W., Hersh, E. M., Snively, J., Diaz, M. I., Miles, S., Liu, X., Obrocea, M., Qiu, Z., et al. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181611420 · Cited by 82
Cancer Immunotherapy and Nanomedicine
Sheng, W.-Y., & Huang, L. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0258-8 · Cited by 85
New technologies for making vaccines
Ellis, R. W. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00416-2 · Cited by 84
Regulation of skeletal alpha-actin promoter in young chickens during hypertrophy caused by stretch overload
Carson, J. A., Yan, Z., Booth, F. W., Coleman, M., Schwartz, R. J., & Stump, C. S. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.268.4.c918 · Cited by 83
Particle-mediated nucleic acid immunization
Haynes, J. R., McCabe, D. E., Swain, W. F., Widera, G., & Fuller, J. T. (1996) · Journal of Biotechnology · doi:10.1016/0168-1656(96)80298-7 · Cited by 83
DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2
Bourne, N., Milligan, G. N., Schleiss, M. R., Bernstein, D. I., & Stanberry, L. R. (1996) · Vaccine · doi:10.1016/s0264-410x(96)00027-8 · Cited by 83
Understanding nucleic acid sensing and its therapeutic applications
Kong, L.-Z., Kim, S., Wang, C., Lee, S. Y., Oh, S., Lee, S., Jo, S., & Kim, T. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01118-6 · Cited by 88
“…and RNA vaccines consisting the nucleic acids of target genes, are injected directly into the body to induce innate and adaptive immune responses 144,145 . pDNA is an intrinsic adjuvant for DNA vaccines and is essential for the activation of resident antigen-presenting cells through activation…”
Background
In vivo gene electrotransfer into skeletal muscle: effects of plasmid DNA on the occurrence and extent of muscle damage
Durieux, A., Bonnefoy, R., Busso, T., & Freyssenet, D. G. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.534 · Cited by 82
DNA vaccines for viral diseases
Davis, H. L., & McCluskie, M. J. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)80009-4 · Cited by 82
Cell Transplantation as an Experimental Treatment for Duchenne Muscular Dystrophy
Law, P. K., Goodwin, T. G., Fang, Q., Deering, M. B., Duggirala, V., Larkin, C., Florendo, J. A., Kirby, D. S., Li, H., Chen, M., et al. (1993) · Cell Transplantation · doi:10.1177/096368979300200607 · Cited by 82
Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines
Häuser, H., Shen, L., Gu, Q.-L., Krueger, S., & Chen, S.-Y. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302160 · Cited by 82
Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects
Huang, T., Peng, L., Han, Y., Wang, D., He, X., Wang, J., & Ou, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.922301 · Cited by 87
“As a new method of cancer therapy, the significant advantages of LNP-based mRNA vaccines are reflected in the following aspects: (1) the significant advantage of mRNA vaccines compared to other treatment lies in the efficacy, safety, and productive efficiency of mRNA vaccines; (2) with the rapid development of nanotec…”
BackgroundMethod
Development of mRNA vaccines against respiratory syncytial virus (RSV)
Qiu, X., Xu, S., Lu, Y., Luo, Z., Yan, Y., Wang, C., & Ji, J. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.10.001 · Cited by 86
Gene doping: the hype and the reality
Wells, D. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.144 · Cited by 84
High-efficiency plasmid gene transfer into dystrophic muscle
Gollins, H., McMahon, J. M., Wells, K. E., & Wells, D. J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301927 · Cited by 81
Ensuring safety of DNA vaccines
Glenting, J., & Wessels, S. (2005) · Microbial Cell Factories · doi:10.1186/1475-2859-4-26 · Cited by 81
Delivery and expression of pDNA embedded in collagen matrices
Cohen-Sacks, H., Elazar, V., Gao, J., Golomb, A., Adwan, H., Korchov, N., Levy, R. J., Berger, M. R., & Golomb, G. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.11.001 · Cited by 81
Human Atrial Natriuretic Peptide Gene Delivery Reduces Blood Pressure in Hypertensive Rats
Lin, K.-F., Chao, J., & Chao, L. (1995) · Hypertension · doi:10.1161/01.hyp.26.6.847 · Cited by 81
Continuous Erythropoietin Delivery by Muscle-Targeted Gene Transfer Using in Vivo Electroporation
Maruyama, H., Sugawa, M., Moriguchi, Y., Imazeki, I., Ishikawa, Y., Ataka, K., Hasegawa, S., Ito, Y., Higuchi, N., Kazama, J. J., et al. (2000) · Human Gene Therapy · doi:10.1089/10430340050015897 · Cited by 81
Gene and cell‐mediated therapies for muscular dystrophy
Konieczny, P., Swiderski, K., & Chamberlain, J. S. (2012) · Muscle & Nerve · doi:10.1002/mus.23738 · Cited by 83
DNA and mRNA vaccination against allergies
Scheiblhofer, S., Thalhamer, J., & Weiss, R. (2018) · Pediatric Allergy and Immunology · doi:10.1111/pai.12964 · Cited by 81
Effect of Cholesterol Content of Lipid Composition in mRNA-LNPs on the Protein Expression in the Injected Site and Liver After Local Administration in Mice
Kawaguchi, M., Noda, M., Ono, A., Kamiya, M., Matsumoto, M., Tsurumaru, M., Mizukami, S., Mukai, H., & Kawakami, S. (2022) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2022.12.026 · Cited by 83
Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles
Rodríguez‐Gascón, A., del Pozo‐Rodríguez, A., & Solinís, M. Á. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s39810 · Cited by 79
Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine
Ward, G. B., Rieder, E. A., & Mason, P. W. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7442-7447.1997 · Cited by 79
Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical results
Isner, J. M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00115-4 · Cited by 80
Genetic Vaccines: Strategies for Optimization
Gregoriadis, G. (1998) · Pharmaceutical Research · doi:10.1023/a:1011950415325 · Cited by 80
COVID-19 in Human, Animal, and Environment: A Review
Swelum, A. A., Shafi, M. E., Albaqami, N. M., El‐Saadony, M. T., Elsify, A. M., Abdo, M., Taha, A. E.-S., Abdel‐Moneim, A. E., Al-Gabri, N. A., Almaiman, A. A., et al. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.00578 · Cited by 83
“RNA vaccines can reduce efficient immunity against several infectious diseases and certain cancers (96, 97).”
Background
HIV mRNA Vaccines—Progress and Future Paths
Mu, Z., Haynes, B. F., & Cain, D. W. (2021) · Vaccines · doi:10.3390/vaccines9020134 · Cited by 84
“Later, it was found that even direct injection of naked mRNA into mouse skeletal muscle results in protein translation and expression [107,108].”
Background
Current view on novel vaccine technologies to combat human infectious diseases
Matić, Z., & Šantak, M. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11713-0 · Cited by 83
Bacterial viruses as human vaccines?
Clark, J. R., & March, J. B. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.4.463 · Cited by 79
Gellan gum blended PEI nanocomposites as gene delivery agents: Evidences from in vitro and in vivo studies
Goyal, R., Tripathi, S. K., Tyagi, S., Ram, K. R., Ansari, K. M., Shukla, Y., Chowdhuri, D. K., Kumar, P., & Gupta, K. C. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.01.009 · Cited by 79
Bacteriophage-mediated nucleic acid immunisation
Clark, J. R., & March, J. B. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00344-4 · Cited by 79
The Effect of Eukaryotic Expression Vectors and Adjuvants on DNA Vaccines in Chickens Using an Avian Influenza Model
Suarez, D. L., & Schultz‐Cherry, S. (2000) · Avian Diseases · doi:10.2307/1593058 · Cited by 79
Nucleic Acid Vaccine Encoding gD2 Protects Mice from Herpes Simplex Virus Type 2 Disease
Kriesel, J. D., Spruance, S. L., Daynes, R. A., & Araneo, B. A. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.3.536 · Cited by 79

Authors: Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L.
Affiliations: University of Wisconsin–Madison (US)
Vical (United States) (US)
Departments of Pediatrics and Genetics, Waisman Center, University of Wisconsin, Madison, WI 53706.
ORCID: Malone, Robert W.
Felgner, Philip L.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1990-03-23
Volume: 247
Issue: 4949
Pages: 1465-1468
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.1690918
OpenAlex: W2014495927
Cited by: 4,173
References: 27
Citations by year: 2026: 96 · 2025: 151 · 2024: 186 · 2023: 201 · 2022: 188 · 2021: 187 · 2020: 81 · 2019: 74 · 2018: 62 · 2017: 66 · 2016: 56 · 2015: 77 · 2014: 68 · 2013: 93 · 2012: 90
FWCI: 26.43
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5k11hd000669-02)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 03352, HD00669-05, P30HD003352)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Health Sciences › Medicine › Emergency Medicine › Intramuscular injections and effects
Keywords: in vivo gene delivery, skeletal muscle, intramuscular injection, DNA vectors, chloramphenicol acetyltransferase, luciferase, beta-galactosidase, transgene expression, cytochemical staining, transfection
MeSH terms: Animals, Avian Sarcoma Viruses, Coleoptera, beta-Galactosidase, DNA, Escherichia coli, Genetic Vectors, Histocytochemistry, Luciferases, Muscles, RNA, Transfection, Chloramphenicol O-Acetyltransferase, Gene Expression, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Direct Gene Transfer into Mouse Muscle in Vivo

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks